Stock Fundamentals

Company Information

Company Name
Phibro Animal Health Corporation
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US71742Q1067
CIK: 0001069899
CUSIP: 71742Q106
Currency: USD
Full Time Employees: 2,475
Phone: 201 329 7300
Fiscal Year End: June
IPO Date: Apr 11, 2014
Description:

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Address:

Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712

Directors & Officers

Name Title Year Born
Mr. Jack Clifford Bendheim Chairman, President & CEO 1947
Mr. Glenn C. David Chief Financial Officer 1972
Mr. Larry L. Miller Chief Operating Officer 1964
Ms. Judith A. Weinstein Senior VP, General Counsel & Corporate Secretary 1969
Mr. Daniel M. Bendheim J.D. Executive VP of Corporate Strategy & Director 1972
Mr. Jonathan Bendheim Executive Vice President of Global Technology & People and Director 1976
Ms. Lisa A. Escudero Senior Vice President of Human Resources 1962
Mr. Ramon Fuenmayor President South America Region NA
Mr. Samson Li President of Asia Pacific Region 1972
Mr. Todd Armstrong President of North American Region NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.43M Sep 30, 2025 8.45% $0.00 -1.87%
Vanguard Group Inc 1.54M Dec 31, 2025 3.80% $0.00 0.91%
State Street Corp 894.04K Sep 30, 2025 2.21% $0.00 -1.68%
Acadian Asset Management LLC 785.82K Sep 30, 2025 1.94% $0.06 277.67%
FMR Inc 688.62K Dec 31, 2025 1.70% $0.00 15.24%
Geode Capital Management, LLC 547.16K Sep 30, 2025 1.35% $0.00 -1.40%
Renaissance Technologies Corp 545.30K Dec 31, 2025 1.35% $0.03 -1.78%
Dimensional Fund Advisors, Inc. 492.34K Dec 31, 2025 1.21% $0.00 1.41%
Nuveen, LLC 479.22K Sep 30, 2025 1.18% $0.01 4.24%
JPMorgan Chase & Co 476.23K Sep 30, 2025 1.17% $0.00 3,561.90%
Morgan Stanley - Brokerage Accounts 436.04K Sep 30, 2025 1.08% $0.00 -11.34%
Dana Investment Advisors Inc 328.68K Dec 31, 2025 0.81% $0.36 -7.44%
Amvescap Plc. 322.30K Sep 30, 2025 0.80% $0.00 22.51%
Ranger Investment Management LP 279.43K Dec 31, 2025 0.69% $0.72 -6.83%
Barclays PLC 269.57K Sep 30, 2025 0.67% $0.00 47.43%
Charles Schwab Investment Management Inc 268.65K Dec 31, 2025 0.66% $0.00 -0.93%
Bank of New York Mellon Corp 267.10K Sep 30, 2025 0.66% $0.00 -0.66%
Qube Research & Technologies 255.35K Sep 30, 2025 0.63% $0.01 40.21%
Capricorn Fund Managers Ltd 252.93K Sep 30, 2025 0.62% $3.44 0.00%
CastleKnight Management LP 240.90K Dec 31, 2025 0.59% $0.20 -39.74%

Shares Statistics

Shares Outstanding: 20.62M
Shares Float: 20.46M
% Insiders: 99.30%
% Institutions: 9,708.70%
Short % Float: 6.20%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 BlackRock Inc 3.43M 8.45% ▼ 1.87% Sep 30, 2025
2 Vanguard Group Inc 1.54M 3.80% ▲ 0.91% Dec 31, 2025
3 State Street Corp 894.04K 2.21% ▼ 1.68% Sep 30, 2025
4 Acadian Asset Management LLC 785.82K 1.94% ▲ 277.67% Sep 30, 2025
5 FMR Inc 688.62K 1.70% ▲ 15.24% Dec 31, 2025
6 Geode Capital Management, LLC 547.16K 1.35% ▼ 1.40% Sep 30, 2025
7 Renaissance Technologies Corp 545.30K 1.35% ▼ 1.78% Dec 31, 2025
8 Dimensional Fund Advisors, Inc. 492.34K 1.21% ▲ 1.41% Dec 31, 2025
9 Nuveen, LLC 479.22K 1.18% ▲ 4.24% Sep 30, 2025
10 JPMorgan Chase & Co 476.23K 1.17% ▲ 3,561.90% Sep 30, 2025

Valuation Metrics

Enterprise Value: $2.92B
Trailing P/E: 24.15
Forward P/E: 10.57

Financial Highlights

Market Cap: $2.21B
EBITDA: $228.84M
P/E Ratio: $24.15
PEG Ratio: $1.66
Book Value: $8.20
Dividend/Share: $0.48
Dividend Yield: 0.88%
Earnings/Share: $2.26
Profit Margin: 6.29%
Operating Margin: 14.71%
ROA (TTM): 8.34%
ROE (TTM): 31.80%
Revenue (TTM): $1.46B
Revenue/Share (TTM): $36.13
Earnings Growth (YOY): 752.00%
Revenue Growth (YOY): 20.90%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-06-30 2.76x 2.55x 0.79x 3.32x 4.96x
2024-06-30 2.94x 1.93x 0.74x 2.43x 7.18x
2023-06-30 3.33x 1.70x 0.71x 4.00x 4.54x
2022-06-30 2.97x 1.67x 0.72x 6.53x 3.75x
2021-06-30 3.04x 1.67x 0.72x 7.20x 3.62x
2020-06-30 2.87x 2.09x 0.76x 4.84x 3.87x
2019-06-30 3.02x 0.50x 0.70x 5.36x 0.96x
2018-06-30 2.90x 0.45x 0.72x 8.31x 0.66x
2017-06-30 3.14x 0.47x 0.76x 6.57x 0.58x
2016-06-30 3.15x 0.79x 0.85x 5.09x 0.61x
2015-06-30 2.82x 0.20x 0.94x 6.02x 0.05x
2014-06-30 2.66x 19.10x 0.97x 1.93x 4.76x
2013-06-30 2.57x -5.30x 1.15x 1.59x 5.03x
2012-06-30 2.40x -3.97x 1.20x 1.38x 5.28x
2011-06-30 N/A N/A N/A 1.19x 0.00x
2010-06-30 N/A N/A N/A 1.60x 0.00x
2009-06-30 0.00x N/A 1.15x 0.95x -5.99x
2008-06-30 0.00x N/A 1.12x 1.09x -11.19x
2007-06-30 1.96x -2.82x 1.32x 0.77x -10.86x
2006-06-30 1.75x -0.10x 1.34x 0.71x -0.32x
2005-06-30 1.79x -4.11x 1.18x 0.16x -6.42x
2004-06-30 1.54x -2.66x 1.26x 2.12x 15.79x
2003-06-30 1.06x -1.68x 1.31x 1.49x -9.99x
2002-06-30 1.38x -3.04x 1.21x 0.60x -4.39x
2001-06-30 1.59x 50.64x 0.99x 0.31x -7.62x
2000-06-30 2.14x 4.76x 0.88x 1.11x 12.90x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 20, 2026 Jack Bendheim N/A Sale 7.04K $51.42 $362.00K
Feb 18, 2026 Jack Bendheim N/A Sale 7.04K $51.40 $361.86K
Feb 13, 2026 Jack Bendheim N/A Sale 7.04K $51.96 $365.80K
Feb 11, 2026 Jack Bendheim N/A Sale 14.18K $51.62 $732.18K
Feb 10, 2026 Jack Bendheim N/A Sale 58.01K $51.81 $3.01M
Feb 05, 2026 Jack Bendheim N/A Sale 110.84K $48.38 $5.36M
Feb 04, 2026 Jack Bendheim N/A Sale 3.52K $41.15 $144.85K
Feb 03, 2026 Jack Bendheim N/A Sale 9.66K $41.47 $400.60K
Jan 30, 2026 Jack Bendheim N/A Sale 6.69K $40.09 $268.32K
Jan 29, 2026 Jack Bendheim N/A Sale 6.77K $40.12 $271.69K
Jan 23, 2026 Jack Bendheim N/A Sale 1.24K $40.55 $50.08K
Jan 22, 2026 Jack Bendheim N/A Sale 13.16K $41.98 $552.37K
Jan 21, 2026 Jack Bendheim N/A Sale 14.69K $41.68 $612.15K
Jan 15, 2026 Jack Bendheim N/A Sale 2.93K $40.02 $117.34K
Jan 14, 2026 Jack Bendheim N/A Sale 3.65K $40.53 $147.98K
Jan 13, 2026 Jack Bendheim N/A Sale 7.55K $40.32 $304.46K
Jan 09, 2026 Jack Bendheim N/A Sale 213.00 $40.16 $8.55K
Jan 07, 2026 Jack Bendheim N/A Sale 328.00 $40.09 $13.15K
Dec 11, 2025 Jack Bendheim N/A Sale 5.75K $40.93 $235.43K
Dec 09, 2025 Jack Bendheim N/A Sale 1.29K $40.19 $51.76K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PAHC.US!